CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization

Archives of Virology

Volumn 148, Issue 3, 2003, Pages 435-448

  Encke, Jens ^a,b   Zu Putlitz, J ^a   Stremmel, W ^a   Wands, J R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANTS, IMMUNOLOGIC; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNIZATION; IMMUNIZATION SCHEDULE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; OLIGODEOXYRIBONUCLEOTIDES; T-LYMPHOCYTES; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL HEPATITIS VACCINES;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; HEPATITIS C VIRUS;

EID: 0037334936     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-002-0935-y     Document Type: Article

References (39)

1. Befeler AS, Di Bisceglie AM (2002) Hepatocellular carcinoma: Diagnosis and treatment. Gastroenterology 122: 1609-1619
2. Chattergoon M, Boyer J, Weiner DB (1997) Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J 11: 753-763
3. Cho HJ, Hayashi T, Datta SK, Takabayashi K, Van Uden JH, Horner A, Corr M, Raz E (2002) IFN-alphabeta promote priming of antigen-specific CD8(+) and CD4(+) T lymphocytes by immunostimulatory DNA-based vaccines. J Immunol 168: 4907-4913
4. Davis HL, Weeranta R, Waldschmidt TJ, Tygrett L, Schorr J, Krieg AM (1998) CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol 160: 870-876
5. Davis HL (2000) CpG motifs for optimization of DNA vaccines. Dev Biol 104: 165-169
6. Encke J, zu Putlitz J, Geissler M, Wands JR (1998) Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. J Immunol 161: 4917-4923
7. Encke J, zu Putlitz J, Wands JR (1999) DNA vaccines. Intervirology 42: 117-124
8. Encke J, Wands JR (2000) Ethanol inhibition: the humoral and cellular immune response to hepatitis C virus NS5 protein after genetic immunization [In Process Citation]. Alcohol Clin Exp Res 24: 1063-1069
9. Geissler M, Gesien A, Tokushige K, Wands JR (1997) Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 158: 1231-1237
10. Geissler M, Tokushige K, Wakita T, Zurawski VR, Wands JR (1998) Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs. Vaccine 16: 857-867
11. Gurunathan S, Klinman DM, Seder RA (2000) DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18: 927-974
12. Houghton M (2000) Strategies and prospects for vaccination against the hepatitis C viruses. Curr Top Microbiol Immunol 242: 327-339
13. Inchauspe G (1997) Gene vaccination for hepatitis C. Springer Semin Immunopathol 19: 211-221
14. Inchauspe G, Major ME, Nakano I, Vitvitski L, Trepo C (1997) DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Vaccine 15: 853-856
15. Inchauspe G, Vitvitski L, Major ME, Jung G, Spengler U, Maisonnas M, Trepo C (1997) Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 16: 185-195
16. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 161: 3042-3049
17. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM (1996) CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 93: 2879-2883
18. Klinman DM, Yamshchikov G, Ishigatsubo Y (1997) Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158: 3635-3639
19. Klinman DM, Sechler JM, Conover J, Gu M, Rosenberg AS (1998) Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J Immunol 160: 2388-2392
20. Klinman DM, Barnhart KM, Conover J (1999) CpG motifs as immune adjuvants. Vaccine 17: 19-25
21. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretsky GA, Klinman DM (1995) CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374: 546-549
22. Krieg AM (1999) CpG DNA: a novel immunomodulator. Trends Microbiol 7: 64-65
23. Krieg AM (2002) CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 20: 709-760
24. Lagging LM, Meyer K, Hoft D, Houghton M, Belshe RB, Ray R (1995) Immune responses to plasmid DNA encoding the hepatitis C virus core protein. J Virol 69: 5859-5863
25. Lauer GM, Walker BD (2001) Hepatitis C virus infection. N Engl J Med 345: 41-52
26. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358: 958-965
27. McCluskie MJ, Davis HL (1998) CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J Immunol 161: 4463-4466
28. McDonnell WM, Askari FK (1996) DNA vaccines. N Engl J Med 334: 42-45
29. Oxenius A, Martinic MM, Hengartner H, Klenerman P (1999) CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines. J Virol 73: 4120-4126
30. Poynard T, McHutchison J, Manns M, Trepo C, Lindsay K, Goodman Z, Ling MH, Albrecht J (2002) Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 122: 1303-1313
31. Redford TW, Yi AK, Ward CT, Krieg AM (1998) Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J Immunol 161: 3930-3935
32. Rehermann B, Chisari FV (2000) Cell mediated immune response to the hepatitis C virus. Curr Top Microbiol Immunol 242: 299-325
33. Roman M, Martin-Orozco E, Goodman JS, Nguyen MD, Sato Y, Ronaghy A, Kornbluth RS, Richman DD, Carson DA, Raz E (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3: 849-854
34. Saito T, Sherman GJ, Kurokohchi K, Guo ZP, Donets M, Yu MY, Berzofsky JA, Akatsuka T, Feinstone SM (1997) Plasmid DNA-based immunization for hepatitis C virus structural proteins: immune responses in mice. Gastroenterology 112: 1321-1330
35. Sato Y, Roman M, Tighe H, Lee D, Corr M, Nguyen MD, Silverman GJ, Lotz M, Carson DA, Raz E (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273: 352-354
36. Theodore D, Fried MW (2000) Natural history and disease manifestations of hepatitis C infection. Curr Top Microbiol Immunol 242: 43-54
37. Thomas DL (2000) Hepatitis C epidemiology. Curr Top Microbiol Immunol 242: 25-41
38. Tokushige K, Wakita T, Pachuk C, Moradpour, Weiner DB, Zurawski Jr VR, Wands JR (1996) Expression and immune response to hepatitis C virus core DNA-based vaccine constructs. Hepatology 24: 14-20
39. Tokushige K, Moradpour D, Wakita T, Geissler M, Hayashi N, Wands JR (1997) Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. J Virol Methods 64: 73-80